NOTCH1 has been established as an oncogenic driver in several tumor models such as T-ALL [2], CLL [32], MCL [6], and a wide range of solid tumors [4], where activation recurs in different phases of the disease, both at diagnosis and relapse [2,33,34]. Here, NOTCH1 is linked to B-cell chronic lymphocytic leukemia.